GlassScriptPhysician profile
Daniel A Rodriguez
NPI 1982960175
$10,915.48
in general payments reported to CMS, 2019-2025
37 companies · $3,370 in 2025
The $3,370 reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $916 · 2020: $501 · 2021: $740 · 2022: $1,738 · 2023: $1,696 · 2024: $1,954 · 2025: $3,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,986 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,985.65 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,917.44 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Genzyme Corporation | $1,748.57 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $939.78 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Regeneron Healthcare Solutions, INC. | $921.94 | 2019-2025 | Dupixent |
| Kaleo, INC. | $564.45 | 2019-2024 | Auvi-Q |
| Pfizer INC. | $496.83 | 2019-2025 | |
| Leo Pharma INC. | $496.07 | 2022-2025 | Adbry, Anzupgo |
| Ars Pharmaceuticals Operations, INC. | $462.50 | 2025 | Neffy |
| Novartis Pharmaceuticals Corporation | $405.01 | 2023-2025 | |
| Galderma Laboratories, L.P. | $354.81 | 2024-2025 | Nemluvio |
| Amgen INC. | $306.06 | 2022-2025 | Tezspire |
| Optinose US, INC. | $302.04 | 2019-2025 | |
| Abbvie INC. | $265.76 | 2022-2023 | Rinvoq |
| Covis Pharma Gmbh | $234.36 | 2019-2023 | |
| Incyte Corporation | $207.51 | 2021-2025 | Opzelura |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.